Outcome of Board Meeting for increase in authorised share capital and issue and allotment of Equity Shares through preferential basis

t , Archit Organosys Limited Q- 903, Sth Floor, Venus Benecia, Nr. Pakwan Restaurant, Bodakdev, S. G. Highway, ® Ahmedabad-380054, Gujarat, India. Date: 34 September, 2026 BSE Limited Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai - 400 001. Dear Sir/ Ma’am, Sub: Outcome of Board Meeting held today Thursday, 3rd September, 2026 Ref: BSE Scrip Code: 524640 | ISIN: INE078101011 Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors at its meeting held today i.e, Thursday, 3 September, 2026 at the registered office of the Company situated at 903, 9% Floor, Venus Benecia, Near Pakwan Restaurant, Bodakdev, S. G. Highway, Ahmedabad, Gujarat, India - 380 054, which commenced at 04:00 P.M. and concluded at 05:30 P.M, inter-alia has, considered and approved: Increase in Authorised Share Capital of the Company from Rs. 25,00,00,000/- (Rupees Twenty-Five Crores Only), divided into 2,50,00,000 (Two Crores Fifty Lakhs) Equity Shares of Rs. 10/- (Rupees Ten Only) each, to Rs. 60,00,00,000/- (Rupees Sixty Crores Only), divided into 6,00,00,000 (Six Crores) Equity Shares of Rs. 10/- (Rupees Ten Only) each, and alteration of the Capital Clause in the Memorandum of Association, subject to the approval of the shareholders at the ensuing Annual General Meeting. . Issuance of up to 3,72,48,344 equity shares by way of a preferential issue, for consideration other than cash, through swap of equity shares, at an issue price of Rs. 65.00/- per equity share (face value Rs. 10/- premium Rs. 55/-), to the Proposed Allottee(s) belonging to the “Promoter and Promoter Group” and “Non-Promoter” categories, in consideration for acquisition of 1,86,24,172 equity shares (92.20% of paid-up equity share capital) of M/s. Archit Life Science Limited (“Target Company”), ata valuation of Rs. 130.00/- per equity share (face value Rs. 10/-, premium Rs. 120/-), subject to approval of the shareholders of the Company at the ensuing Annual General Meeting and such other regulatory and statutory approvals as may be required under applicable law. Other requisite details/ disclosures regarding the issuance of securities under Regulation 30 of SEBI (LODR) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/155 dated November 11, 2024, are attached herewith as Annexure - I. In terms of the Section 62(1)/(C) of the Companies Act, 2013 read with Rule 13 oft he Companies (Share Capital and Debentures) Rules, 2014, a valuation report from M /s. Procurve Valux Private Limited, a Registered Valuer Entity having Registration No. IBBI/RV-E/02/2025/2018, Ahmedabad, has been obtained. The Relevant Date, in terms of provisions of SEBI (ICDR) Regulations, 2018, for the preferential issue is Monday, 31%August, 2026. Kindly take the same on your record and oblige us. Thanking You. For Archit Organosys Limited KANDARP 0.5ty KRISHNAK frstiotm ANT AMIN 715 530 Kandarp Amin Chairman and Whole-time Director DIN: 00038972 Phone: +91-79-26573340/48925370 Unit: Survey No.228/A, Paiki 7, Paiki 2, Vil-l Naargmaed, Bhavnagar-364313, Guarat, India E-MAIL: accounts@architorg.com | export@architorg.com | share@architorg.com | trading@architorg.com | Website: wwiw.architorg.com Archit Organosys Limited 903, 9th Floor, Venus Benecia, Nr. Pakwan Restaurant, Bodakdev, S. G. Highway, AoL’ Ahmedabad-380054, Gujarat, India. CIN: 1241106)1993PLC019941 Annexure -1 Disclosures regarding the issuance of securities under Re; lation 30 of SEBI (LODR) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/155 dated November 11, 2024 sr. Particulars Details No. (Agenda No. 2) 1. | Type of securities proposed to be issued Equity Shares (viz. equity shares, convertibles etc) 2. | Type of issuance Preferential Issue for consideration other than cash e, (further public offering, rights issue, depository | swap of shares. receipts (ADR/ GDR), qualified institutions placement, preferential allotment etc.) 3. | Total number of securities proposed to be | e Archit Organosys Limited: 3,72,48,344 Equity issued or the total amount for which the Shares securities will be issued (approximately) o Archit Life Science Limited: 1,86,24,172 Equity Shares (Preferential issue for consideration other than cash, through swap of Equity Shares.) 4. | Name of Investors As per Annexure - A 5. | Post allotment of securities — outcome of the | As per Annexure - B subscription, issue price / allotted price (in case of convertibles), number of investors. 6. | In case of convertibles - intimation on the | Not Applicable conversion of securities or on lapse of the tenure oft he instrument Annexure - A sr. Name of proposed allottee(s) No. of Equity Shares No. to be allotted 1. Kandarp Krishnakant Amin 54,72,000 2. Archana Kandarp Amin 54,72,000 3. Archit Kandarpbhai Amin 24,72,000 4. Suchit Kandarp Amin 46,09,028 5. Manini Suchit Amin 46,11,658 6. Shimoli Archit Amin 46,11,658 7. Joshi Jetal Himanshu 4,33,340 8. Paras Anoobhai Shah 3,25,000 9. Manjulaben G Joshi 4,33,340 10. | Manek Tradecon Private Limited 4,33,340 11. | Patil Jignasha Sagar 3,03,340 12. | Shobha Bhatt 3,03,340 13. | Aartiben Bhatt 3,03,340 14. | Kalpesh Chandravadan Shah 2,81,660 15. | Taffon Advisory Consultancy LLP 12,08,300 16. | Suketu Lalitbhai Raja 4,33,340 17. | Vala Balvantsinh Ajitsinh 2,16,660 18. | Kanabar Rakesh Natvarlal 1,08,340 19. | Chintan Jatin Sheth 2,16,660 20. | Prakash Ratilal Parikh 2,50,000 21. | Parikh Kalpana Prakashbhai 2,50,000 22. | Prakash Ratilal Parikh (HUF) 2,50,000 23. | siddhrajsinh Gohil 1,25,000 24. | ShreySiddhrajsinh Gohil 1,25,000 25. | Hanshaben Siddhrajbhai Gohil 1,25,000 26. | Dishva Gohil 1,25,000 27. | Darshit Bharatkumar (HUF) 2,08,240 28. | Janakkumar Dhansukhlal Shah 2,08,240 Phone: +91-79-26573340/48925370 Unit: Survey No.228/A, Paiki 7, Paiki 2, Vil-l Naargmaed, Bhavnagar-364313, Guarat, India E-MAIL: accounts@architorg.com | export@architorg.com | share@architorg.com | trading@architorg.com | Website: wwiw.architorg.com Archit Organosys Limited 903, Sth Floor, Venus Benecia, Nr. Pakwan Re‘sAthaumreadnatb,a dB-o3d8a0k0d5e4v,, SG.u jGa.r aHti,g hInwdaiya,. AoL’ CIN: 124110GJ1993PLC019941 29. | Binaben Janakbhai Shah 2,08,240 30. | Kamal Ramprasad Ringwala 2,08,240 31. | Bharat Himmatlal Shah-HUF 2,08,240 32. | Jignasa Kamalkant Ringwala 2,08,240 33.__| Divyaprabhaben Pravinbhai Shah 4,16,560 34. | Bhavnaben Jayeshkumar Bhimani 1,42,840 35. | Jignesh Jayeshkumar Bhimani 3,13,720 36. | Zarna Jigneshkumar Bhimani 1,42,880 37. | Bhavin Jayesh Bhimani 3,13,700 38.__| Darshini Bhavin Bhimani 1,42,840 39. | Parin Jayesh Bhimani 3,13,700 40. | Riddhi Parin Bhimani 1,42,880 41. | Jayeshkumar Prabhudas Bhimani (HUF) 1,42,880 42. | Jignesh Jayeshkumar Bhimani (HUF) 1,42,840 43.__| Bhavin Jayeshbhai Bhimani (HUF) 1,42,880 44.__| Parin Jayesh Bhimani (HUF) 1,42,840 Total 3,72,48,344 Annexur-e B Sr.] Naof mpropeosed Category of Pre-preferential Numberof | ‘Post-Preferential No. allottee(s) Shareholders Equity No.of | %held | Shares No. of % held Equity proposedto | Equity Shares be Shares held held Allotted 1. | Kandarp Krishnakant | Promoter 4411132 2150 | 5472000 | 9883132 | 17.11 Amin 2._| ArchanaKandarp Amin_|_Promoter 46,222,943 2253 | 54,72,000 | 1,0094943 | 1747 3. [Archit Kandarpbhai | Promoter 17,04,095 830 | 2472000 | 4176095 7.23 Amin 4. | SuchitKandaArmipn | Promoter 17,80,721 868 | 4609028 | 6389749 | 1106 Group 5. | Manini Suchit Amin Promoter 5,00,000 244 | 4611658 | 5111658 8.85 Group 6. | Shimoli Archit Amin Promoter 5,00,000 244 | 4611658 | 5111658 8.85 Group 7. | Joshi Jetal Himanshu Non-Promoter 0 0.00 433340 433,340 075 8. | Paras Anoobhai Shah | Non-Promoter [ 0.00 3,25,000 3,25,000 056 9. | ManjulaG bJoeshni NonPromoter 0 0.00 433,340 433,340 075 10. | Manek Tradecon Private | Non-Promoter 0 0.00 433340 433,340 075 Limited 11. | Patil Jignasha Sagar NonPromoter 0 0.00 3,03,340 3,03,340 053 12. | Shobha Bhatt Non-Prom [Showing first 8,000 characters — download PDF for full document]